HCG Protocol for Fertility Preservation on TRT

Last Updated: OCTOBER 2024

Long-term testosterone therapy without human chorionic gonadotropin (hCG) results in azoospermia or severe oligozoospermia in 90% of men, highlighting the critical need for fertility-sparing protocols (J Sex Med, 2017). For men considering or already on Testosterone Replacement Therapy (TRT) who wish to preserve their fertility, understanding the role of hCG is paramount. Exogenous testosterone effectively treats hypogonadal symptoms, but its impact on the delicate hormonal axis controlling sperm production can be profound and detrimental without strategic intervention. This guide details how hCG can be integrated into a TRT protocol to maintain the potential for biological fatherhood.

The Impact of TRT on Male Fertility

Testosterone Replacement Therapy works by introducing synthetic testosterone into the body. While this addresses the symptoms of low testosterone, it also signals to the brain that sufficient androgen levels are present. This signal suppresses the hypothalamic-pituitary-gonadal (HPG) axis. Specifically, the hypothalamus reduces its release of gonadotropin-releasing hormone (GnRH), which in turn diminishes the pituitary gland’s secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

LH and FSH are the primary drivers of natural testosterone production and spermatogenesis. LH stimulates the Leydig cells in the testes to produce endogenous testosterone. FSH acts directly on the Sertoli cells within the seminiferous tubules, which are crucial for nurturing developing sperm cells. When LH and FSH are suppressed by exogenous testosterone, the testes shrink, endogenous testosterone production ceases, and critically, sperm production significantly declines or stops entirely. This leads to impaired fertility or complete infertility, even if serum testosterone levels are optimized. The conventional total testosterone threshold of 300 ng/dL, often cited as the lower limit for hypogonadism, stems from studies including older, less healthy populations, and may not reflect optimal ranges for younger men seeking fertility. Many men experience symptoms and desire treatment even at higher “normal” levels.

The Role of HCG in Fertility Preservation on TRT

Human Chorionic Gonadotropin (hCG) is a glycoprotein hormone that mimics the action of LH. By introducing exogenous hCG, we can bypass the suppressed pituitary and directly stimulate the Leydig cells in the testes. This stimulation encourages the testes to continue producing endogenous testosterone, which is essential for maintaining intratesticular testosterone concentrations. These intratesticular testosterone levels are significantly higher than serum levels and are crucial for supporting spermatogenesis.

“HCG administration provides testicular stimulation in a fashion analogous to LH, preventing testicular atrophy and maintaining spermatogenesis during exogenous testosterone therapy,” states a review in Fertility and Sterility (2014) by Patel et al. This direct testicular stimulation helps prevent the severe suppression of sperm production that typically occurs with TRT alone. HCG does not directly replace FSH, but by maintaining intratesticular testosterone, it helps preserve the testicular microenvironment necessary for sperm health.

HCG Dosing Protocols for Fertility on TRT

The primary goal of incorporating hCG with TRT for fertility is to maintain sperm production while still achieving optimal systemic testosterone levels. Dosing varies, but common protocols aim for consistent testicular stimulation.

Concurrent HCG with TRT

This is the most common approach for men who wish to preserve fertility while undergoing ongoing TRT.

• Testosterone (Cypionate or Enanthate): Typically 100–200mg per week, administered intramuscularly (IM) or subcutaneously (SQ) in two equal doses (e.g., 50–100mg twice per week). This keeps serum testosterone levels stable and symptoms managed.
• HCG: 500–1000 IU administered subcutaneously (SQ) 2-3 times per week. A common protocol is 500 IU twice per week (e.g., Monday and Thursday) or 250 IU three times per week (e.g., Monday, Wednesday, Friday).
  • Example Schedule: If using 100mg testosterone cypionate twice weekly, a patient might inject 500 IU of hCG on the same days, or spaced evenly.
  • Rationale: This consistent dosing strategy ensures regular Leydig cell stimulation, maintaining intratesticular testosterone and testicular size.

HCG for Fertility Restoration (Post-TRT or as Standalone)

For men who have been on TRT without hCG and wish to restore fertility, or those with hypogonadotropic hypogonadism (low LH/FSH) and fertility as a primary goal, a more intensive or standalone hCG protocol may be used. These protocols often prioritize sperm production over immediate symptom relief and may be followed by a transition to TRT with concurrent hCG once fertility is achieved.

• HCG (standalone): 1000–2500 IU 2-3 times per week, often for several months, sometimes escalating if sperm parameters do not improve.
• Addition of FSH: In cases of prolonged TRT-induced suppression or severe hypogonadotropic hypogonadism, the Sertoli cells might need direct FSH stimulation. Exogenous FSH (e.g., menotropins or recombinant FSH) can be added. The “Baylor 2025 protocol” often involves hCG (e.g., 3000 IU) combined with FSH (e.g., 75 IU) three times weekly, though this is a more specialized approach for established infertility.

Managing Estradiol (E2) with HCG

HCG stimulates Leydig cells to produce testosterone, but it also increases the activity of aromatase, an enzyme that converts testosterone into estrogen (estradiol or E2). Elevated E2 can lead to undesirable side effects like gynecomastia, water retention, and mood swings. Therefore, monitoring E2 levels is crucial when using hCG.

• Monitoring: Regular blood tests for E2 are essential. Target E2 levels on TRT with hCG are typically 20–40 pg/mL.
• Anastrozole (Aromatase Inhibitor): If E2 levels rise too high and symptoms of estrogen excess are present, a low dose of an aromatase inhibitor (AI) like anastrozole may be considered.
  • Typical Anastrozole dose: 0.25–0.5mg once or twice per week, adjusted based on E2 levels.
  • Caution: Over-suppressing E2 can be detrimental, leading to joint pain, libido issues, and bone density concerns. Anastrozole should only be used symptomatically and carefully. Many men can manage TRT + hCG without an AI if dosing is optimized.

Monitoring and Lab Values

Regular blood work and semen analyses are critical to ensure the protocol is effective and safe.

Hormonal Panels

• Total Testosterone: Aim for levels between 500–1000 ng/dL at trough (just before your next testosterone injection).
• Free Testosterone: Target 15–25 pg/mL.
• Estradiol (E2): Aim for 20–40 pg/mL on TRT.
• LH & FSH: Expect these to be suppressed by exogenous testosterone. If using hCG as a standalone to stimulate natural production, these may rise depending on the underlying cause.
• Prolactin, SHBG, CBC (Hematocrit): Important for overall health monitoring on TRT.

Sperm Analysis

Semen analysis (sperm count, motility, morphology) should be performed before starting TRT, at 3-6 month intervals after initiating TRT with hCG, and again when actively trying to conceive. While hCG helps, sperm parameters may still be somewhat lower than in men not on TRT.

Alternative Fertility-Sparing Approaches: Enclomiphene

For some men, especially those with mild hypogonadism who prioritize fertility, Enclomiphene citrate may be a viable alternative to traditional TRT with hCG. Enclomiphene is a selective estrogen receptor modulator (SERM) that blocks estrogen’s negative feedback at the hypothalamus and pituitary. This leads to increased GnRH, LH, and FSH secretion, thereby stimulating the testes to produce more endogenous testosterone and maintain spermatogenesis.

• Enclomiphene Dosing: Typically 12.5–25mg daily.
• Advantages: Directly stimulates natural testosterone production and preserves the HPG axis, thus generally maintaining fertility more robustly than TRT alone.
• Disadvantages: May not achieve the same testosterone levels or provide the same symptom relief as exogenous testosterone in all men.

Comparison of Fertility-Sparing Protocols